The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018 ; volume:7 ; number:1 ; day:15 ; month:8 ; year:2019 ; pages:1-12 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (15.8.2019), 1-12, 12.2019
- Urheber
-
Ascierto, Paolo A.
Butterfield, Lisa H.
Demaria, Sandra
Ferris, Robert L.
Freeman, Gordon J.
Lo, Roger S.
Mantovani, Alberto
Nathan, Paul
Hamid, Omid
Politi, Katerina
Puzanov, Igor
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0683-0
- URN
-
urn:nbn:de:101:1-2020010113061691766048
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ascierto, Paolo A.
- Butterfield, Lisa H.
- Demaria, Sandra
- Ferris, Robert L.
- Freeman, Gordon J.
- Lo, Roger S.
- Mantovani, Alberto
- Nathan, Paul
- Hamid, Omid
- Politi, Katerina
- Puzanov, Igor
- SpringerLink (Online service)
Ähnliche Objekte (12)
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Melanoma: the role of surgery in the era of new therapies
What have we learned from cancer immunotherapy in the last 3 years?
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Combination therapy: the next opportunity and challenge of medicine
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)
The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019
Melanoma: A model for testing new agents in combination therapies
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Melanoma: the role of surgery in the era of new therapies
What have we learned from cancer immunotherapy in the last 3 years?
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Combination therapy: the next opportunity and challenge of medicine
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)
The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019
Melanoma: A model for testing new agents in combination therapies
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Melanoma: the role of surgery in the era of new therapies
What have we learned from cancer immunotherapy in the last 3 years?
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Combination therapy: the next opportunity and challenge of medicine
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)
The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019
Melanoma: A model for testing new agents in combination therapies
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application